Helena J Teede and colleagues’ global consensus to rename polycystic ovary syndrome (PCOS) as polyendocrine metabolic ovarian syndrome (PMOS) is an important advance.1 The previous term is ...

Polycystic ovary syndrome (PCOS) has been renamed polyendocrine metabolic ovarian syndrome (PMOS). Professor Helena Teede led this name change after 14 years of research and global collaboration. But ...

PCOS increases the risk of infertility and can lead to the need for ovulatory induction. This is the fourth installment of a 6-part series on the lifelong journey of polycystic ovary syndrome (PCOS) ...

A global effort led by Monash University has changed the name of a significant women's health condition that was misunderstood to be "all about ovarian cysts." Polyendocrine metabolic ovarian syndrome ...

Heart disease risk has been found to increase in women with polycystic ovary syndrome (PCOS), even in those with normal weight, according to research presented at the 28th European Congress of ...

Polycystic Ovary Syndrome (PCOS) has been renamed Polyendocrine Metabolic Ovary Syndrome (PMOS) to hopefully emphasize its effects on metabolic and cardiovascular health, and to encourage a ...

PCOS has been renamed PMOS. Here's what the change means for the millions of women living with this misunderstood, often misdiagnosed condition ...

The Canadian researchers also found obesity, dyslipidemia (abnormal levels of fat in your blood) and Type 2 diabetes to be two to three times more common for women with PCOS. And most importantly, ...

Decades-long campaign powered by patient perspectives results in switch from PCOS – a name that caused confusion and undue suffering – to PMOS What is PCOS, what are the symptoms and treatment, and ...

PCOS can accelerate the development of increased risk of atherosclerosis and cardiovascular disease. This is the fifth installment of a 6-part series on the lifelong journey of polycystic ovary ...